Marina

Dr. Marina is an expert in the field of cancer medicine, with a particular focus on cutting-edge advancements in cancer research and treatment. She has extensive experience in covering developments related to cancer therapies, medical breakthroughs, and emerging trends in the oncology space. Along with this, she also cover USA News and recent updates of Social Security and IRS Updates.

Survivors in Synch: Breast Cancer Survivors Paddle Toward Victory and Healing

Survivors in Synch: Breast Cancer Survivors Paddle Toward Victory and Healing

Every afternoon, six days a week, a group of strong, determined women in Lycra gear gather at Nathan Benderson Park in Florida. They step ...

|
USA BMX hosts a cancer fundraising and race in Topeka

USA BMX hosts a cancer fundraising and race in Topeka

Get ready for a weekend of bikes, racing, and community spirit in Topeka! Heartland BMX is bringing back its annual Race For Life fundraiser ...

|
Uterine Cancer Cases May Rise by Over 50% by 2050, Black Women at Highest Risk

Uterine Cancer Cases May Rise by Over 50% by 2050, Black Women at Highest Risk

A new study from Columbia University, published in Cancer Epidemiology, Biomarkers & Prevention on July 1, 2025, has raised serious concerns about the rising ...

|
Lung Cancer Treatment Market Set to Soar, Projected to Reach $73.29 Billion by 2033

Lung Cancer Treatment Market Set to Soar, Projected to Reach $73.29 Billion by 2033

The global lung cancer treatment market is expanding quickly, thanks to better treatments and growing awareness. In 2024, the market reached $32.64 billion, and ...

|
https://www.1011now.com/2024/07/20/new-vape-regulations-go-into-effect-across-nebraska/

Regeneron’s New Cancer Drug Lynozyfic Approved by US FDA

Regeneron Pharmaceuticals has received a big thumbs-up from the US Food and Drug Administration (FDA) for its new blood cancer drug called Lynozyfic. This ...

|
Memorial Sloan Kettering and UnitedHealthcare Reach New Agreement for Uninterrupted Cancer Care Access

Memorial Sloan Kettering and UnitedHealthcare Reach New Agreement for Uninterrupted Cancer Care Access

In a positive development for cancer patients, Memorial Sloan Kettering Cancer Center (MSK) and UnitedHealthcare (UHC) have announced a new, multiyear agreement ensuring continued ...

|
Rising Uterine Cancer Rates in the U.S.: A Growing Concern for Black Women

Rising Uterine Cancer Rates in the U.S.: A Growing Concern for Black Women

Uterine cancer cases in the United States are projected to rise sharply by 2050, with Black women facing disproportionately higher risks, including a threefold ...

|
Quarterly Review of FDA Oncology Approvals: New Hope for Cancer Patients

Quarterly Review of FDA Oncology Approvals: New Hope for Cancer Patients

The U.S. Food and Drug Administration (FDA) has approved 13 new oncology treatments between April 1 and June 30, 2025. These approvals introduce novel ...

|
UnitedHealthcare and Memorial Sloan Kettering Reach New Agreement Amid Contract Dispute

UnitedHealthcare and Memorial Sloan Kettering Reach New Agreement Amid Contract Dispute

In a major development for cancer patients, UnitedHealthcare and Memorial Sloan Kettering Cancer Center (MSK) announced on Tuesday that they had reached a multi-year ...

|
AI Breakthrough in Cancer Research: A New Tool to Target Tumor Cell Diversity

AI Breakthrough in Cancer Research: A New Tool to Target Tumor Cell Diversity

In a groundbreaking study led by Prof. Smita Krishnaswamy from Yale, a multinational team of researchers has developed an advanced AI tool called AAnet. ...

|
123…6 Next